Multidisciplinary training in cardiovascular engineering

项目摘要 尽管人们付出了巨大的努力，医学也取得了许多进步，但心脏病仍然是导致心脏病的主要原因。 在美国，每年有四分之一的人死亡。在2010年，这些治疗 在美国，每6美元的医疗保健支出中，疾病就占1美元。 心血管设备只会随着心血管疾病的发病率增加， 人口增长，人口老龄化，医疗技术不断进步。为了解决以上的 需求，我们需要生物医学工程师与适当的先进的多学科 教育培训拟议的T32培训计划是专门为教育， 培训，并在生物医学工程经验锐化博士生，在一个 多学科背景下，专门从事临床医生和临床科学家， 端在他们作为实习生参加博士前两年的学习期间， 明尼苏达大学（UMN）建立的生物医学工程研究生课程，六个 每年的学员将以多种方式与强大的培训教师互动，包括 除了开始他们的博士研究独特的活动： ·完成高级心脏生理学和解剖学课程（由 UMN-美敦力可视心脏实验室合作的领导者）和心血管器械 （由当地心血管器械公司专家授课）; ·在UMN心血管诊所之一完成临床沉浸; ·参加创新系列讲座（通过UMN医疗器械中心提供）; ·参加每月一次的临床重点午餐会，邀请临床医生介绍具体的 心血管疾病和相关的医疗器械限制;以及 ·参加每月的专业发展午餐会，邀请演讲者 广泛的职业机会，包括医疗技术公司研发，FDA和专利法。 我们将招募一批多样化的学员，该计划将定期由一个 咨询委员会，以确保其在各方面取得成功。我们预计， 我们的学员的多学科研究和观点将使他们能够满足 通过推动未来的技术进步，无论是研发， 心血管器械公司的工程师、联邦实验室的器械监管机构，或 教授们领导着他们自己的心血管工程研究项目。

Project Summary In spite of great effort and many medical advances, heart disease remains the leading cause of death in the United States causing 1 in 4 deaths annually. In 2010, the treatment of these diseases accounted for about $1 of every $6 spent on healthcare in the U.S. The demand for cardiovascular devices is only going to increase as the incidence of cardiovascular diseases rises, the population ages, and medical technology continues to advance. To help meet this demand, we need biomedical engineers with the appropriate advanced multidisciplinary education and training. The proposed T32 training program is designed uniquely to educate, train, and experientially sharpen doctoral students in biomedical engineering, within a multidisciplinary context that specifically engages clinicians and clinician-scientists towards that end. During their participation as trainees in their first two years of predoctoral study in the University of Minnesota (UMN)'s established biomedical engineering graduate program, six trainees per year will interact with a strong training faculty in numerous ways, including these distinctive activities beyond commencing their doctoral research: • complete the courses Advanced Cardiac Physiology and Anatomy (organized by the leader of UMN-Medtronic Visible Heart Lab collaboration) and Cardiovascular Devices (taught by local cardiovascular device company experts); • complete a clinical immersion in one of the UMN cardiovascular clinics; • attend an innovation lecture series (offered through the UMN Medical Devices Center); • attend monthly clinical focus lunches with invited clinicians presenting specific cardiovascular diseases and associated medical device limitations; and • attend monthly professional development lunches with invited speakers addressing broad career opportunities including medtech company R&D, FDA, and patent law. We will recruit a diverse group of trainees, and the program will be reviewed periodically by an advisory committee to ensure its success in all respects. We expect that the resulting multidisciplinary research and perspective of our trainees will enable them to meet the aforementioned demand by driving future technological advancements, either as R&D engineers at cardiovascular device companies, device regulators at federal labs, or as professors leading their own research programs in cardiovascular engineering.